Fintel reports that on December 18, 2024, BTIG initiated coverage of Real Brokerage (NasdaqCM:REAX) with a Buy recommendation. Analyst Price Forecast Suggests 48.49% Upside As of December 3 ...
Hope Therapeutics, a wholly-owned subsidiary of NRx Pharmaceuticals (NRXP), announced engagement of BTIG, a leading global financial services ...
Alex Rodriguez, Eli Manning, Brooke Shields, Padma Lakshmi, Shaq and other celebs close deals for the brokerage's 13th Annual Commissions for Charity Day. This was a record-breaking year for BTIG in ...
BTIG is a global financial services firm specializing ... electronic and outsource trading, investment banking, prime brokerage, capital introduction, corporate access, research and strategy ...
As of December 3, 2024, the average one-year price target for Real Brokerage is $7.40/share. The forecasts range from a low of $6.56 to a high of $8.40. The average price target represents an ...
HOPE Therapeuticsâ„¢, Inc. ("HOPE"), a medical and technology driven company, and a wholly-owned subsidiary of NRx ...
NEW YORK--(BUSINESS WIRE)--BTIG announced today that it will commit to donating $1 million dollars to wildfire relief and restoration efforts in Los Angeles, California. The funds will be donated ...